Virax Biolabs Group Limit... (VRAX)
NASDAQ: VRAX
· Real-Time Price · USD
0.96
-0.01 (-1.13%)
At close: Jun 06, 2025, 11:33 AM
Virax Biolabs Stock Forecast
Stock Price Forecast
The 1 analysts with 12-month price forecasts for VRAX stock have an median target of 3, with a low estimate of 3 and a high estimate of 3. The median target predicts an increase of 212.50% from the current stock price of 0.96.
Latest Analyst Insight Report
According to 1 stock analyst, the rating for Virax Biolabs Group Limited is "Buy". This means that the analyst believes this stock is likely to lead to higher returns than market as a whole.
Financial Forecast this Year
Revenue This Year
25K
from 156.42K
Increased by -84%
Revenue Next Year
40K
from 25K
Increased by 60.0%
EPS This Year
-1.48
from -3.36
Increased by 56.0%
EPS Next Year
-1.01
from -1.48
Increased by 31.8%